• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

股腘动脉支架置入术的六个月结果及白细胞介素-6的预测价值:与高敏C反应蛋白的比较

Six-month results of stenting of the femoropopliteal artery and predictive value of interleukin-6: Comparison with high-sensitivity C-reactive protein.

作者信息

Guo Songlin, Zhang Zhang, Wang Lei, Yuan Liangxi, Bao Junmin, Zhou Jian, Jing Zaiping

机构信息

Department of General Surgery, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.

Department of Vascular Surgery, Changhai Hospital, Second Military Medical University, Shanghai, China.

出版信息

Vascular. 2020 Dec;28(6):715-721. doi: 10.1177/1708538120921005. Epub 2020 May 14.

DOI:10.1177/1708538120921005
PMID:32408853
Abstract

OBJECTIVES

To determine the association of pre- and postinterventional serum levels of interleukin-6 and high-sensitivity C-reactive protein at the six-month evaluation of restenosis after stenting of the femoropopliteal artery.

METHODS

Sixty-eight consecutive patients with steno-occlusive femoropopliteal artery disease of Rutherford category III or IV who underwent stent implantation were included. Six-month patency was evaluated with color-coded duplex ultrasound. The association of in-stent restenosis with interleukin-6 and high-sensitivity C-reactive protein levels at baseline, and 24-h postintervention was assessed with a multivariate logistic regression analysis.

RESULTS

In-stent restenosis was found in 15 patients (22.1%) within six months. Interleukin-6 and high-sensitivity C-reactive protein levels were significantly increased at 24-h postintervention compared to their preintervention values ( < 0.001 and  = 0.002, respectively). Interleukin-6 values at baseline (odds ratio, 1.11; 95% confidence interval: 1.00, 1.23;  = 0.044) and 24-h postintervention (odds ratio, 1.04; 95% confidence interval: 1.02, 1.06;  < 0.001) were independently associated with six-month in-stent restenosis. Twenty-four-hour postinterventional high-sensitivity C-reactive protein levels were also found to be related to restenosis (odds ratio, 1.15; 95% confidence interval: 1.04, 1.26;  = 0.006), but high-sensitivity C-reactive protein levels at baseline did not show an independent association with in-stent restenosis (odds ratio, 0.57; 95% confidence interval: 0.35, 1.80;  = 0.667). Smoking, diabetes mellitus, and cumulative stent length were other parameters associated with an increased risk for in-stent restenosis.

CONCLUSIONS

Femoropopliteal artery angioplasty with stent placement induces an inflammatory response. Interleukin-6 is a powerful independent predictor of intermediate-term outcomes for stenting of the femoropopliteal artery, suggesting that its predictive value may be superior to that of high-sensitivity C-reactive protein.

摘要

目的

在股腘动脉支架置入术后6个月再狭窄评估中,确定介入前后血清白细胞介素-6和高敏C反应蛋白水平之间的关联。

方法

纳入68例连续接受支架植入术的卢瑟福III或IV级股腘动脉狭窄闭塞性疾病患者。采用彩色编码双功超声评估6个月通畅情况。通过多因素逻辑回归分析评估支架内再狭窄与基线及介入后24小时白细胞介素-6和高敏C反应蛋白水平之间的关联。

结果

15例患者(22.1%)在6个月内出现支架内再狭窄。与介入前相比,介入后24小时白细胞介素-6和高敏C反应蛋白水平显著升高(分别为<0.001和=0.002)。基线时白细胞介素-6值(比值比,1.11;95%置信区间:1.00,1.23;=0.044)和介入后24小时白细胞介素-6值(比值比,1.04;95%置信区间:1.02,1.06;<0.001)与6个月支架内再狭窄独立相关。还发现介入后24小时高敏C反应蛋白水平与再狭窄有关(比值比,1.15;95%置信区间:1.04,1.26;=0.006),但基线时高敏C反应蛋白水平与支架内再狭窄无独立关联(比值比,0.57;95%置信区间:0.35,1.80;=0.667)。吸烟、糖尿病和累计支架长度是与支架内再狭窄风险增加相关的其他参数。

结论

股腘动脉血管成形术加支架置入会引发炎症反应。白细胞介素-6是股腘动脉支架置入中期结局的有力独立预测指标,表明其预测价值可能优于高敏C反应蛋白。

相似文献

1
Six-month results of stenting of the femoropopliteal artery and predictive value of interleukin-6: Comparison with high-sensitivity C-reactive protein.股腘动脉支架置入术的六个月结果及白细胞介素-6的预测价值:与高敏C反应蛋白的比较
Vascular. 2020 Dec;28(6):715-721. doi: 10.1177/1708538120921005. Epub 2020 May 14.
2
PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.PEACE I 所有受试者注册研究:4 法国规格的 Pulsar-18 自膨式镍钛合金支架植入股腘动脉病变后的通畅性评估
J Endovasc Ther. 2014 Jun;21(3):373-80. doi: 10.1583/13-4637R.1.
3
Impact of IVUS-Derived Vessel Size on Midterm Outcomes After Stent Implantation in Femoropopliteal Lesions.血管内超声指导下的血管大小对股腘动脉病变支架植入术后中期结果的影响。
J Endovasc Ther. 2020 Feb;27(1):77-85. doi: 10.1177/1526602819896293.
4
Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.紫杉醇洗脱球囊与标准球囊血管成形术治疗股浅动脉和腘动脉支架内再狭窄:PACUBA 试验 1 年结果。
JACC Cardiovasc Interv. 2016 Jul 11;9(13):1386-92. doi: 10.1016/j.jcin.2016.04.012.
5
PTA and Stenting of Femoropopliteal Trunk With Cordis Smartflex Stent System: A Single-Center Experience.使用科迪斯Smartflex支架系统对股腘动脉主干进行经皮腔内血管成形术和支架置入术:单中心经验
Vasc Endovascular Surg. 2020 Jan;54(1):17-24. doi: 10.1177/1538574419875551. Epub 2019 Sep 16.
6
Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease.使用螺旋编织镍钛诺支架治疗股腘动脉闭塞性疾病时再狭窄的预测因素。
J Vasc Surg. 2015 Nov;62(5):1201-9. doi: 10.1016/j.jvs.2015.05.030. Epub 2015 Jul 11.
7
Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year.一年后初次治疗 TASC C 和 D 型股腘动脉病变时支架断裂的发生率及其对临床的影响。
Eur J Vasc Endovasc Surg. 2013 Aug;46(2):201-12. doi: 10.1016/j.ejvs.2013.05.010. Epub 2013 Jun 15.
8
Impact of Plaque Calcification and Stent Oversizing on Clinical Outcomes of Atherosclerotic Femoropopliteal Arterial Occlusive Disease Following Stent Angioplasty.支架血管成形术后斑块钙化和支架过度扩张对股腘动脉粥样硬化性闭塞性疾病临床转归的影响。
Eur J Vasc Endovasc Surg. 2019 Aug;58(2):215-222. doi: 10.1016/j.ejvs.2019.01.025. Epub 2019 Mar 9.
9
Drug-Eluting Stent vs Percutaneous Transluminal Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: Results From a Retrospective 1-Year Multicenter Study.药物洗脱支架与经皮腔内血管成形术治疗股腘动脉支架内再狭窄:一项回顾性1年多中心研究的结果
J Endovasc Ther. 2016 Aug;23(4):642-7. doi: 10.1177/1526602816642195. Epub 2016 Apr 20.
10
Intravascular ultrasound measurements after drug-eluting stent placement in femoropopliteal lesions: determining predictors of restenosis.药物洗脱支架置入股腘动脉病变后血管内超声测量:确定再狭窄的预测因素
J Endovasc Ther. 2015 Jun;22(3):341-9. doi: 10.1177/1526602815580308. Epub 2015 Apr 10.

引用本文的文献

1
Current Prognostic Biomarkers for Peripheral Arterial Disease: A Comprehensive Systematic Review of the Literature.外周动脉疾病的当前预后生物标志物:文献的全面系统综述
Metabolites. 2025 Mar 25;15(4):224. doi: 10.3390/metabo15040224.
2
Systematic Review on the Role of IL-6 and IL-1β in Cardiovascular Diseases.白细胞介素-6和白细胞介素-1β在心血管疾病中作用的系统评价
J Cardiovasc Dev Dis. 2024 Jul 1;11(7):206. doi: 10.3390/jcdd11070206.
3
A Systematic Review of Interleukins as Diagnostic and Prognostic Biomarkers for Peripheral Artery Disease.
白细胞介素作为外周动脉疾病诊断和预后生物标志物的系统评价。
Biomolecules. 2023 Nov 12;13(11):1640. doi: 10.3390/biom13111640.
4
Multi-Modality Imaging of Atheromatous Plaques in Peripheral Arterial Disease: Integrating Molecular and Imaging Markers.动脉粥样硬化斑块的多模态成像:整合分子和成像标志物。
Int J Mol Sci. 2023 Jul 5;24(13):11123. doi: 10.3390/ijms241311123.
5
Characteristics, Antithrombotic Patterns, and Prognostic Outcomes in Claudication and Critical Limb-Threatening Ischemia Undergoing Endovascular Therapy.腔内治疗的跛行和严重肢体缺血的特征、抗栓模式和预后结果。
J Endovasc Ther. 2024 Aug;31(4):622-633. doi: 10.1177/15266028221134886. Epub 2022 Nov 23.
6
Predictive Value of Perioperative Cytokine Levels on the Risk for In-Stent Restenosis in Acute Myocardial Infarction Patients.围手术期细胞因子水平对急性心肌梗死患者支架内再狭窄风险的预测价值。
Contrast Media Mol Imaging. 2022 Apr 23;2022:7832564. doi: 10.1155/2022/7832564. eCollection 2022.
7
Circulating Biomarkers in Lower Extremity Artery Disease.下肢动脉疾病中的循环生物标志物
Eur Cardiol. 2022 Mar 23;17:e09. doi: 10.15420/ecr.2021.58. eCollection 2022 Feb.
8
The Role of Circulating Biomarkers in Peripheral Arterial Disease.循环生物标志物在周围动脉疾病中的作用
Int J Mol Sci. 2021 Mar 30;22(7):3601. doi: 10.3390/ijms22073601.
9
Successful Peripheral Vascular Intervention in Patients with High-risk Comorbidities or Lesion Characteristics.高危合并症或病变特征患者的外周血管介入治疗的成功。
Curr Cardiol Rep. 2021 Mar 5;23(4):32. doi: 10.1007/s11886-021-01465-8.